loader
Please Wait
Applying Filters...

Approved Marketing Authorisations (MA) containing NCGC00024708-06 in Europe. Original Data : EMA Website

Menu
$ API Ref.Price (USD/KG) : 1,007Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1CELGENE EUROPE LIMITED

02 1Celgene Europe Ltd

03 1Celgene Europe Ltd.,

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

thalidomide

Brand Name : Thalidomide Celgene

Dosage Form : HARD CAPSULES

Dosage Strength : 50 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

02

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Thalidomide

Brand Name : Thalidomide Celgene

Dosage Form : Thalidomide 50Mg 28 Combined Oral Use

Dosage Strength : 28 cps 50 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

03

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Thalidomide

Brand Name : Thalidomide Celgene

Dosage Form : Capsule, hard

Dosage Strength : 50 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank